Provided by Tiger Trade Technology Pte. Ltd.

Aethlon Medical

1.98
-0.0301-1.50%
Post-market: 1.93-0.0482-2.43%19:57 EST
Volume:12.71K
Turnover:24.90K
Market Cap:2.60M
PE:-0.04
High:2.04
Open:1.95
Low:1.93
Close:2.01
52wk High:49.58
52wk Low:1.86
Shares:1.32M
Float Shares:1.31M
Volume Ratio:0.32
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-48.4600
EPS(LYR):-85.7749
ROE:-208.60%
ROA:-62.88%
PB:0.39
PE(LYR):-0.02

Loading ...

Aethlon Medical to Present at Emerging Growth Conference

Reuters
·
Yesterday

Aethlon Medical Posts Q3 Results, Highlights Hemopurifier Progress

TIPRANKS
·
Feb 13

Aethlon Medical Q3 operating expenses up 13.6% yr/yr

Reuters
·
Feb 13

AEMD Q3 operating expenses rise 13.6% to USD 2.06 million

Reuters
·
Feb 13

Aethlon Medical Q3 EPS $(2.45) Beats $(2.57) Estimate

Benzinga
·
Feb 13

Press Release: Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update

Dow Jones
·
Feb 13

Aethlon Medical Inc. veröffentlicht demnächst neue Quartalszahlen und lädt zur Investorenkonferenz ein

Reuters
·
Feb 04

Aethlon Medical Amends Warrants to Allow Immediate Exercise

TIPRANKS
·
Jan 27

Aethlon Medical Inc. Announces Date for Upcoming Annual Stockholder Meeting

Reuters
·
Jan 17

BRIEF-Aethlon Medical Inc Files For Common Stock Offering Of $15 Million, SEC Filing Shows

Reuters
·
Dec 24, 2025

Aethlon Medical Inc: Files for Common Stock Offering of $15 Mln - SEC Filing

THOMSON REUTERS
·
Dec 24, 2025

BRIEF-Aethlon Medical Announces Pricing Of A Private Placement And Warrant Inducement

Reuters
·
Dec 05, 2025

Press Release: Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million

Dow Jones
·
Dec 05, 2025

Aethlon Medical Reports Hemopurifier Removes Inflammatory Extracellular Vesicles in Long COVID Study

Reuters
·
Dec 02, 2025

Maxim Group Reaffirms Their Hold Rating on Aethlon Medical (AEMD)

TIPRANKS
·
Nov 14, 2025

Aethlon Medical Reports Q2 Cost Reduction and Ongoing Cancer Trial Progress

Reuters
·
Nov 13, 2025

Aethlon Medical Q2 EPS $(3.74) Misses $(3.66) Estimate

Benzinga
·
Nov 13, 2025

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

THOMSON REUTERS
·
Nov 13, 2025

Aethlon Medical Inc - Qtrly Loss per Share $3.74

THOMSON REUTERS
·
Nov 13, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 12, 2025